Kiss E et al. Lipidprofil vizsgálata szisztémás lupus erythematosusos betegekben, különös tekintettel a lipoprotein(a) jelentőségére lupusnephritisben. (2004) ORVOSI HETILAP 0030-6002 1788-6120 145 5 217-222,
1091689
Szakcikk (Folyóiratcikk) | Tudományos[1091689]
Wong C.Y. et al. Cardiovascular risk factors and complications in patients with systemic lupus erythematosus with and without nephritis: a systematic review and meta-analysis. (2024) LUPUS SCIENCE AND MEDICINE 2053-8790 2053-8790 11 1
Missala I et al. A systematic literature review of the association of lipoprotein(a) and autoimmune diseases and atherosclerosis. (2012) INTERNATIONAL JOURNAL OF RHEUMATOLOGY 1687-9260 1687-9279 2012
Dwivedi J et al. Study of homocysteine, lipoprotein (a), lipid profile with oxidative stress in nephrotic syndrome and lupus nephritis. (2010) RESEARCH JOURNAL OF PHARMACEUTICAL BIOLOGICAL AND CHEMICAL SCIENCES 0975-8585 0975-8585 1 3 670-679
Urquizu-Padilla M et al. Changes in lipid profile between flare and remission of patients with systemic lupus erythematosus: A prospective study. (2009) JOURNAL OF RHEUMATOLOGY 0315-162X 1499-2752 36 8 1639-1645
Lopez-Pedrera C et al. Genomics and proteomics: a new approach for assessing thrombotic risk in autoimmune diseases. (2008) LUPUS 0961-2033 1477-0962 17 10 904-915
Ohtsuka T. Combinational effect of low-dose oral corticosteroid and mizoribine for ulcerative colitis in a patient with systemic sclerosis. (2010) JOURNAL OF DERMATOLOGY 0385-2407 37 1 71-74
Kiss E et al. Lipidprofil és paraoxonáz aktivitás vizsgálata szisztémás lupus erythematosusban. (2005) ORVOSI HETILAP 0030-6002 1788-6120 146 47 2395-2402,
1091699
Szakcikk (Folyóiratcikk) | Tudományos[1091699]
Ganjali Shiva et al. High-density lipoprotein functionality in systemic lupus erythematosus. (2020) SEMINARS IN ARTHRITIS AND RHEUMATISM 0049-0172 1532-866X 50 4 769-775
Bahrehmand F et al. Paraoxonase (PON1) 55 polymorphism and association with systemic lupus erythematosus. (2013) IRANIAN JOURNAL OF ALLERGY ASTHMA AND IMMUNOLOGY 1735-1502 1735-5249 12 3 211-219
Yilmaz S et al. Association between serum total antioxidant status and coronary microvascular functions in patients with SLE. (2012) ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES 0742-2822 1540-8175 29 10 1218-1223
Tarr T et al. Primer antifoszfolipid szindróma: a szisztémás lupus erythematosus előfutára? [Is the primary antiphospholipid syndrome a forerunner of SLE?]. (2005) ORVOSI HETILAP 0030-6002 1788-6120 146 5 203-207,
1091705
Perl A.. Metabolic control of lupus pathogenesis: central role for activation of the mechanistic target of rapamycin. (2020) Megjelent: Systemic Lupus Erythematosus: Basic, Applied and Clinical Aspects pp. 267-276
Oaks Zachary et al. Mitochondrial Dysfunction in the Liver and Antiphospholipid Antibody Production Precede Disease Onset and Respond to Rapamycin in Lupus-Prone Mice. (2016) ARTHRITIS & RHEUMATOLOGY 2326-5191 2326-5205 68 11 2728-2739
Rastmanesh R. Alopecia and ocular alterations: A role for Minoxidil. (2010) JOURNAL OF RECEPTOR AND SIGNAL TRANSDUCTION 1079-9893 1532-4281 30 3 189-192
Kiss E et al. Reduced Flow-mediated Vasodilation as a Marker For Cardiovascular Complications in Lupus Patients. (2006) JOURNAL OF AUTOIMMUNITY 0896-8411 1095-9157 27 4 211-217,
1091723
Biswas Tapobrata et al. Subclinical Atherosclerosis and Endothelial Dysfunction in Cases of Systemic Lupus Erythematosus: A Hospital-Based Case-Control Study. (2024) CUREUS 2168-8184 16 8
Semalulu Teresa et al. Managing Cardiovascular Risk in Systemic Lupus Erythematosus: Considerations for the Clinician. (2023) IMMUNOTARGETS AND THERAPY 2253-1556 2253-1556 12 175-186
Richter Patricia et al. Non-Traditional Pro-Inflammatory and Pro-Atherosclerotic Risk Factors Related to Systemic Lupus Erythematosus. (2022) INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 1661-6596 1422-0067 23 20
Stanisavljevic Natasa et al. Asymmetric Dimethylarginine Is a Marker of Endothelial Dysfunction in Thrombotic Antiphospholipid Syndrome Patients. (2022) INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 1661-6596 1422-0067 23 20
S Shrookmousa et al. Serum Osteoprotegerin Level as a Risk Factor for Atherosclerosis in Systemic Lupus Erythematosus Patients: A Cross Sectional Study. (2021) BIOMEDICAL AND PHARMACOLOGY JOURNAL 0974-6242 2456-2610 14 3 1435-1447
Li Jiamin et al. Oxidative Stress-Induced Ferroptosis in Cardiovascular Diseases and Epigenetic Mechanisms. (2021) FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY 2296-634X 2296-634X 9
Huang Jinghui et al. CD34(+) CD133(+) CD309(+) circulating angiogenic cell level is reduced but positively related to hydroxychloroquine use in SLE patients-a case control study and meta-regression analysis. (2021) RHEUMATOLOGY (UNITED KINGDOM) 1462-0324 1462-0332 60 8 3936-3944
Hedar A.M. et al. Autoimmune rheumatic diseases and vascular function: The concept of autoimmune atherosclerosis. (2021) JOURNAL OF CLINICAL MEDICINE 2077-0383 10 19
Huang Zhenhua et al. Vitamin D (1,25-(OH)2D3) Improves Endothelial Progenitor Cells Function via Enhanced NO Secretion in Systemic Lupus Erythematosus. (2020) CARDIOLOGY RESEARCH AND PRACTICE 2090-0597 2090-8016 2020
Tselios Konstantinos et al. Impact of the new American College of Cardiology/American Heart Association definition of hypertension on atherosclerotic vascular events in systemic lupus erythematosus. (2020) ANNALS OF THE RHEUMATIC DISEASES 0003-4967 1468-2060 79 5 612-617
Mendoza-Pinto Claudia et al. Endothelial dysfunction and arterial stiffness in patients with systemic lupus erythematosus: A systematic review and meta-analysis. (2020) ATHEROSCLEROSIS 0021-9150 1879-1484 297 55-63
Ammar Waleed et al. Assessment of vascular stiffness using different modalities in patients with systemic lupus erythematosus: a case control study. (2020) EGYPTIAN HEART JOURNAL 1110-2608 2090-911X 72 1
Choi Harry et al. Application of Non-invasive Imaging in Inflammatory Disease Conditions to Evaluate Subclinical Coronary Artery Disease. (2020) CURRENT RHEUMATOLOGY REPORTS 1523-3774 1534-6307 22 1
Sciatti Edoardo et al. Systemic Lupus Erythematosus and Endothelial Dysfunction: A Close Relationship. (2019) CURRENT RHEUMATOLOGY REVIEWS 1573-3971 1875-6360 15 3 177-188
Garcia-Carrasco Mario et al. The Role of Circulating Regulatory T Cell Levels on Subclinical Atherosclerosis and Cardiovascular Risk Factors in Women with Systemic Lupus Erythematosus. (2018) MEDIATORS OF INFLAMMATION 0962-9351 1466-1861
Arida Aikaterini et al. Systemic Inflammatory Response and Atherosclerosis: The Paradigm of Chronic Inflammatory Rheumatic Diseases. (2018) INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 1661-6596 1422-0067 19 7
Osmundo Gilmar S et al. Large Artery Dysfunction in Primary Antiphospholipid Syndrome. (2018) JCR : JOURNAL OF CLINICAL RHEUMATOLOGY 1076-1608 1536-7355 24 1 14-17
Moroni Luca et al. Evaluation of Endothelial Function by Flow-Mediated Dilation: a Comprehensive Review in Rheumatic Disease. (2017) ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS 0004-069X 1661-4917 65 6 463-475
Butbul Aviel Y et al. Endothelial function in children with a history of henoch schonlein purpura. (2017) PEDIATRIC RHEUMATOLOGY 1546-0096 1546-0096 15 1
Mak Anselm et al. Endothelial dysfunction in systemic lupus erythematosus - a case-control study and an updated meta-analysis and meta-regression. (2017) SCIENTIFIC REPORTS 2045-2322 2045-2322 7
Gunes Hakan et al. Relationship between endothelial dysfunction and microalbuminuria in familial Mediterranean fever. (2016) EUROPEAN JOURNAL OF RHEUMATOLOGY 2147-9720 2148-4279 3 2 61-64
Tselios Konstantinos et al. Optimal Monitoring For Coronary Heart Disease Risk in Patients with Systemic Lupus Erythematosus: A Systematic Review. (2016) JOURNAL OF RHEUMATOLOGY 0315-162X 1499-2752 43 1 54-65
Mikolajczyk T P et al. Heterogeneity of peripheral blood monocytes, endothelial dysfunction and subclinical atherosclerosis in patients with systemic lupus erythematosus. (2016) LUPUS 0961-2033 1477-0962 25 1 18-27
Vera-Lastra O et al. Effect of ezetimibe plus pravastatin on endothelial dysfunction in patients with systemic lupus erythematosus. (2016) LUPUS 0961-2033 1477-0962 25 7 741-748
Andreo Garcia Ana et al. Asymptomatic Atherosclerosis in Primary Sjogren Syndrome: Correlation Between Low Ankle Brachial Index and Autoantibodies Positivity. (2016) JCR : JOURNAL OF CLINICAL RHEUMATOLOGY 1076-1608 1536-7355 22 6 295-298
Sharma S K et al. Assessment of premature atherosclerosis in systemic lupus erythematosus patients with and without nephritis. (2016) LUPUS 0961-2033 1477-0962 25 5 525-531
Conti Fabrizio et al. Subclinical Atherosclerosis in Systemic Lupus Erythematosus and Antiphospholipid Syndrome Focus on β2GPI-Specific T Cell Response. (2014) ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY 1079-5642 1524-4636 34 3 661-668
Mak A et al. Imbalance between endothelial damage and repair: A gateway to cardiovascular disease in systemic lupus erythematosus. (2014) BIOMED RESEARCH INTERNATIONAL 2314-6133 2314-6141 2014
Steyers Curtis M et al. Endothelial Dysfunction in Chronic Inflammatory Diseases. (2014) INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 1661-6596 1422-0067 15 7 11324-11349
Gustafsson JT et al. Definitions of and contributions to cardiovascular disease in systemic lupus erythematosus. (2014) AUTOIMMUNITY 0891-6934 1607-842X 47 2 67-76
dos Reis-Neto ET et al. Supervised physical exercise improves endothelial function in patients with systemic lupus erythematosus. (2013) RHEUMATOLOGY (UNITED KINGDOM) 1462-0324 1462-0332 52 12 2187-2195
Oates JC et al. NADPH oxidase and nitric oxide synthase-dependent superoxide production is increased in proliferative lupus nephritis. (2013) LUPUS 0961-2033 1477-0962 22 13 1361-1370
Akdogan RA et al. Increased Pulse Wave Velocity and Carotid Intima-Media Thickness in Patients with Ulcerative Colitis. (2013) DIGESTIVE DISEASES AND SCIENCES 0163-2116 1573-2568 58 8 2293-2300
Chin CW-L et al. Endothelial function and arterial stiffness assessment as early surrogate markers of vascular risk in patients with systemic lupus erythematosus. (2013) CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 0392-856X 1593-098X 31 2 295-301
Lamb J.J. et al. The effects of tetrahydro-iso-alpha acids and niacin on monocyte-edothelial cell interactions and flow-mediated vasodilation. (2012) Global Advances in Health and Medicine 2164-957X 2164-9561 1 4 84-91
Barnes Jill N et al. Cardiovascular Benefits of Habitual Exercise in Systemic Lupus Erythematosus:A Review. (2012) PHYSICIAN AND SPORTSMEDICINE 0091-3847 2326-3660 40 3 43-48
El-Banawy HS et al. Angiopoietin-2, endothelial dysfunction and renal involvement in patients with systemic lupus erythematosus. (2012) JOURNAL OF NEPHROLOGY 1121-8428 1724-6059 25 4 541-550
Mak A et al. Endothelium-dependent but not endothelium-independent flow-mediated dilation is significantly reduced in patients with systemic lupus erythematosus without vascular events: A metaanalysis and metaregression. (2011) JOURNAL OF RHEUMATOLOGY 0315-162X 1499-2752 38 7 1296-1303
Cugno M et al. Patients with antiphospholipid syndrome display endothelial perturbation. (2010) JOURNAL OF AUTOIMMUNITY 0896-8411 1095-9157 34 2 105-110
Skamra C et al. Management of cardiovascular complications in systemic lupus erythematosus. (2010) INTERNATIONAL JOURNAL OF CLINICAL RHEUMATOLOGY 1758-4272 1758-4280 5 1 75-100
Reynolds JA et al. Vitamin D in systemic lupus erythematosus: Potential beyond bone health. (2009) INTERNATIONAL JOURNAL OF CLINICAL RHEUMATOLOGY 1758-4272 1758-4280 4 3 297-309
Fischer K et al. Diagnosis of early atherosclerotic lesions, and selected atherosclerotic risk factors, in patients with systemic lupus erythematosus. (2009) POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE 0032-3772 1897-9483 119 11 736-742
Borchers AT et al. Smoking cessation: Significance and implications for children. (2008) CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY 1080-0549 1559-0267 34 2 231-249
Meroni PL. Pathogenesis of the antiphospholipid syndrome: An additional example of the mosaic of autoimmunity. (2008) JOURNAL OF AUTOIMMUNITY 0896-8411 1095-9157 30 1-2 99-103
Asherson R A et al. Microvascular and microangiopathic antiphospholipid-associated syndromes ("MAPS"). Semantic or antisemantic?. (2008) AUTOIMMUNITY REVIEWS 1568-9972 1873-0183 7 3 164-167
Tziomalos K et al. Increased risk of vascular events in systemic lupus erythematosus: is arterial stiffness a predictor of vascular risk?. (2008) CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 0392-856X 1593-098X 26 6 1134-1145
Silvariño R et al. Factores de riesgo para aterosclerosis en enfermedades autoinmunitarias. (2008) REVISTA MEDICA DEL URUGUAY 0303-3295 1688-0390 24 2 118-132
Svenungsson E et al. Endothelial function and markers of endothelial activation in relation to cardiovascular disease in systemic lupus erythematosus. (2008) SCANDINAVIAN JOURNAL OF RHEUMATOLOGY 0300-9742 1502-7732 37 5 352-359
Haghjooyejavanmard S et al. Endothelial function and dysfunction: clinical significance and assessment. (2008) JOURNAL OF RESEARCH IN MEDICAL SCIENCES 1735-1995 1735-7136 13 4 207-221
Ghiadoni L et al. Clinical and methodological aspects of endothelial function in patients with systemic autoimmune diseases. (2008) CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 0392-856X 1593-098X 26 4 680-687
Haque S et al. Atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus. (2008) CURRENT OPINION IN LIPIDOLOGY 0957-9672 1473-6535 19 4 338-343
Boren EJ et al. A review of non-cystic fibrosis pediatric bronchiectasis. (2008) CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY 1080-0549 1559-0267 34 2 260-273
Elliott J R et al. The role of preventive cardiology in systemic lupus erythematosus. (2007) CURRENT RHEUMATOLOGY REPORTS 1523-3774 1534-6307 9 2 125-130
Kajiwara T et al. Intracellular trafficking of beta(2)-glycoprotein I complexes with lipid vesicles in macrophages: Implications on the development of antiphospholipid syndrome. (2007) JOURNAL OF AUTOIMMUNITY 0896-8411 1095-9157 29 2-3 164-173
Bocci E B et al. Accelerated atherosclerosis in systemic lupus erythematosus and other connective tissue diaseases. (2007) EXPERT REVIEW OF CLINICAL IMMUNOLOGY 1744-666X 1744-8409 3 4 531-541
Tarr T et al. Tumorok előfordulása szisztémás lupus erythematosusos betegek körében [the Occurrence of Malignancies in a Hungarian Lupus Population]. (2006) ORVOSI HETILAP 0030-6002 1788-6120 147 46 2229-2233,
1091716
Szakcikk (Folyóiratcikk) | Tudományos[1091716]
Santana IU et al. Systemic lupus erythematosus, human papillomavirus infection, cervical pre-malignant and malignant lesions: A systematic review. (2011) CLINICAL RHEUMATOLOGY 0770-3198 1434-9949 30 5 665-672
Barath S et al. Measurement of Natural (cd4+cd25high) And Inducible (cd4+il-10+) Regulatory T Cells in Patients With Systemic Lupus Erythematosus.. (2007) LUPUS 0961-2033 1477-0962 16 7 489-496,
1091744
Szakcikk (Folyóiratcikk) | Tudományos[1091744]
Huang Jinge et al. Imbalance of Th17 cells, Treg cells and associated cytokines in patients with systemic lupus erythematosus: a meta-analysis. (2024) FRONTIERS IN IMMUNOLOGY 1664-3224 1664-3224 15
Aw Yi Tong et al. Immunophenotyping identifies distinct cellular signatures for systemic lupus erythematosus and lupus nephritis. (2023) RHEUMATOLOGY AND AUTOIMMUNITY 2767-1410 2767-1429 3 1 15-25
Tahamoli-Roudsari A. et al. Expression patterns of T cells-specific long noncoding RNAs in systemic lupus erythematosus patients carrying HLA risk/nonrisk alleles. (2023) LUPUS 0961-2033 1477-0962 32 10 1188-1198